Improving colorectal cancer screening for diabetes patients in community health centers
Optimizing Colorectal Cancer Screening among Patients with Diabetes in Safety-Net Primary Care Settings: Targeting Implementation Approaches
This study is looking at how to make colorectal cancer screening easier and more effective for people with diabetes, especially those in low-income communities, so everyone can get the preventive care they need, no matter their background.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10904675 on NIH RePORTER |
What this research studies
This research focuses on enhancing colorectal cancer screening for patients with diabetes, particularly in federally qualified health centers that serve low-income and minority populations. It aims to identify barriers to effective screening and develop tailored strategies to improve access and utilization of screening tests. By examining differences in screening practices among various racial and ethnic groups, the study seeks to ensure that all patients receive appropriate preventive care. The approach includes community engagement and data-driven assessments to inform implementation strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with diabetes, particularly those who are Non-Hispanic Black or Hispanic, and who receive care in federally qualified health centers.
Not a fit: Patients without diabetes or those who do not receive care in safety-net primary care settings may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased colorectal cancer screening rates among diabetes patients, ultimately reducing cancer mortality in this high-risk group.
How similar studies have performed: Previous research has shown that targeted implementation strategies can effectively improve cancer screening rates in underserved populations, indicating potential for success in this approach.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: O'malley, Denalee M. — Rutgers Biomedical and Health Sciences
- Study coordinator: O'malley, Denalee M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.